• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Letter to the Editor
Letter “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
Juan Yang1, Xinyi Li2, Sheng Zheng3
1Department of Gastroenterology, Affiliated Hospital of Yunnan University, Yunnan, 650021, China
2Graduate School of Clinical Medicine, Dali University, Yunnan, 671000, China
3Department of Gastroenterology, The Third People's Hospital of Yunnan Province, Yunnan, 650011, China
Correspondence :  Sheng Zheng ,
Email: zhengsheng_med@163.com
Received: February 24, 2025   Accepted: March 5, 2025
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 315 View
  • 35 Download
Related articles

GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"

Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma

Strategic application of radiotherapy for hepatocellular carcinoma2018 June;24(2)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 713
TOTAL : 2629744
Close layer